Barclays upgraded Ryanair Hldgs from Equal Weight to Overweight
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/25/2024 | Equal Weight → Overweight | Barclays | |
| 7/12/2024 | Buy → Hold | HSBC Securities | |
| 6/21/2024 | Overweight → Equal Weight | Barclays | |
| 6/20/2024 | Buy → Neutral | UBS | |
| 5/24/2024 | Buy → Hold | Deutsche Bank | |
| 1/2/2024 | Outperform → In-line | Evercore ISI | |
| 4/19/2023 | Sell → Buy | Stifel | |
| 1/10/2023 | Overweight | Morgan Stanley |
SC 13G/A - RYANAIR HOLDINGS PLC (0001038683) (Subject)
SC 13G - RYANAIR HOLDINGS PLC (0001038683) (Subject)
SC 13G/A - RYANAIR HOLDINGS PLC (0001038683) (Subject)
6-K - RYANAIR HOLDINGS PLC (0001038683) (Filer)
6-K - RYANAIR HOLDINGS PLC (0001038683) (Filer)
6-K - RYANAIR HOLDINGS PLC (0001038683) (Filer)
U.S. stocks traded higher toward the end of trading, with the NASDAQ Composite gaining around 300 points on Monday. The Dow traded up 0.19% to 40,362.58 while the NASDAQ rose 1.70% to 18,027.77. The S&P 500 also rose, gaining, 1.09% to 5,564.74. Check This Out: Top 4 Real Estate Stocks That May Fall Off A Cliff This Quarter Leading and Lagging SectorsInformation technology shares jumped by 1.7% on Monday. In trading on Monday, energy shares fell by 0.2%. Top Headline Verizon Communications Inc (NYSE:VZ) shares fell around 6% on Monday after it reported fiscal second-quarter results. Its sales increased 0.6% year over year to $32.8 billion, marginally missing the analyst
Shares of CrowdStrike Holdings, Inc. (NASDAQ:CRWD) fell sharply during Monday’s session. Guggenheim analyst John Difucci downgraded the stock from Buy to Neutral, while BTIG analyst Gray Powell downgraded the stock from Buy to Neutral. CrowdStrike shares dipped over 11% on Friday after the company suffered a major outage impacting businesses around the world. Selective Insurance Group shares dipped 13.2% to $264.65 on Friday. Here are some other stocks moving in today’s mid-day session. Gainers MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) shares climbed 148% to $1.98 after the company announced new preclinical study results for its novel oral ketamine analog, Ketamir-2. CareMa
Barclays upgraded Ryanair Hldgs from Equal Weight to Overweight
HSBC Securities downgraded Ryanair Hldgs from Buy to Hold
Barclays downgraded Ryanair Hldgs from Overweight to Equal Weight